14th Feb 2014 16:10
LONDON (Alliance News) - Worldwide Healthcare Trust PLC Friday said it outperformed its benchmark in the last three months of 2013.
In a statement, the trust said its fully diluted net asset value per share total return was 8.8%, meaning it outperformed the MSCI World Health Care Index measured in sterling terms on a total return basis, which rose by 6.4% during the period.
Previously, the trust's benchmark had been the Datastream World Pharmaceutical and Biotechnology Index measured in sterling terms on a total return basis.
"Overall, exposure to North America and also to large capitalisation stocks was increased while holdings in Europe and small capitalisation stocks were reduced. At the stock level, the percentage
holding in Gilead Sciences rose and a position in Regeneron Pharmaceuticals was established while those in Roche and Merck fell," the trust said in a statement.
The trust's shares were Friday quoted at 1,302.56 pence, down 0.44 pence, or 0.03%.
By Samuel Agini; [email protected]; @samuelagini
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Worldwide Healthcare Trust